SCHEDULE: Anson Funds Discloses 8.2% Stake in Applied DNA Sciences
Beneficial Ownership Disclosure
Anson Funds Management LP and its affiliates have disclosed a beneficial ownership of 8.2% in Applied DNA Sciences Inc., totaling 573,538 shares.
Summary
- Anson Funds Management LP, Anson Management GP LLC, Tony Moore, Anson Advisors Inc., Amin Nathoo, and Moez Kassam collectively beneficially own 573,538 shares of Common Stock in APPLIED DNA SCIENCES INC.
- This ownership represents 8.2% of the outstanding Common Stock of APPLIED DNA SCIENCES INC.
- The calculation of the percentage of class is based on 6,497,790 shares of Common Stock issued and outstanding as of May 15, 2025, plus 527,031 shares receivable upon exercise of warrants.
- The beneficial ownership includes shares of Common Stock underlying outstanding warrants, which have beneficial ownership limitations of 4.99% or 9.99% of outstanding Common Stock upon exercise.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: The filing is a factual disclosure of beneficial ownership and does not contain information that would inherently indicate positive or negative sentiment regarding the company's operational or financial performance. It is a neutral regulatory update.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of a significant passive investment stake by an institutional investor group in a publicly traded company. It does not provide specific insights into broader industry trends or competitive landscape beyond the fact of the investment itself.
Stakeholder Impact
- Shareholders: Disclosure of a significant institutional ownership stake may influence market perception and trading activity for APPLIED DNA SCIENCES INC. shares.
Key Dates
| Date | Description |
|---|---|
| 05/15/2025 | Date of Issuer's Quarterly Report on Form 10-Q, reporting 6,497,790 shares of Common Stock issued and outstanding. |
| 06/30/2025 | Date of event which requires the filing of this statement. |
| 08/14/2025 | Signature date for Anson Funds Management LP, Anson Management GP LLC, Tony Moore, Anson Advisors Inc., Amin Nathoo, and Moez Kassam. |
Keywords
APPLIED DNA SCIENCES, Anson Funds, Beneficial Ownership, SEC Filing, Common Stock, Investment Management, Institutional Investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.